study of Apixaban in netherlands

Interferon beta

Amiodarone case safety report.

Ambulatory BP monitoring - elderly

Germany regulatory affairs

GCP inspection findings andthe benefit risk balance-EMEA

Pharmacovigilance System in the Portuguese